Pharmaceutical Industry Case Study

906 Words4 Pages
CHAPTER 8
MAJOR CHALLENGES FACED BY THE INDIAN PHARMACEUTICAL INDUSTRY
The Indian pharmaceutical industry was on a strong growth trajectory in the last decade. It has achieved several milestones. However, the industry needs to tackle various issues related to its operations and regulations. It faces several challenges in the form of pricing of pharmaceutical products and impact of some agreements.
 Impact of GATT-TRIPS agreement
The General Agreement on Tariffs and Trade (GATT) and Trade Related aspects of Intellectual Property Rights (TRIPS) have an adverse impact on pricing of pharmaceutical products. Pharmaceutical companies are not allowed to re-generate existing drugs and formulations and change the existing process and manufacture the
…show more content…
DR. REDDY’S LABORATORIES LTD:
Dr. Reddy 's Laboratories, is an Indian multinational pharmaceutical company head-quartered in Hyderabad, India.
 Revenues INR. 9993.9Crores
 Market Capitalization INR. 59490.29Crores
 Profit INR. 1932.8Crores
 Total No. of Patents in their name 21
 Consolidated Ranking Index 22042.127

DR. REDDY’S LABORATORIES LTD

4. CIPLA:
Cipla is a globally recognized Indian pharmaceutical giant. It ensures to provide patients with access to high quality, affordable and effective medicine and support. Cipla’s mission is to expand their presence as a healthcare company globally, which uses high end technology and innovation to meet daily needs of all patients.
 Revenues INR. 7110.71Crores
 Market Capitalization INR. 39467.24Crores
 Profit INR. 1172.09Crores
 Total No. of Patents in their name 19
 Consolidated Ranking Index 20371.497

Cipla

5. AUROBINDO PHARMA:
Founded in 1986 by Mr. P.V. Ramaprasad Reddy, Mr. K. Nityananda Reddy and a small group of highly active and talented medical professionals, AurobindoPharma was started out off a vision, A vision that promise to touch million lives through their large scale of operation.
 Revenues INR. 9380.29Crores
 Market Capitalization INR.

More about Pharmaceutical Industry Case Study

Open Document